PPI Use May Increase Risk of Community-Acquired Pneumonia
Increased incidence of CAP was noted in stroke patients using PPIs.
Pneumonia
Pneumococcal 15-Valent Conjugate Vaccine Immunogenic, Safe in Healthy Infants
The multicenter, randomized, double-blind, active-comparator-controlled phase 3 PNEU-PED study included 1720 healthy infants enrolled at 42-90 days of age.
Treatment for Pneumocystis Pneumonia Recalled Due to Temperature Control Issue
The recall was initiated because the product had prolonged exposure to extremely cold weather during shipment.
MPR Weekly Dose Podcast Episode 87
This week we have news of the FDA requesting a change to statin prescribing labels, a new vaccine for streptococcus pneumoniae, a new plaque psoriasis cream, a stem cell therapy gets fast tracked as a possible Parkinson disease treatment, and there’s a new treatment approved for Progressive Familial Intrahepatic Cholestasis.
FDA Approves 15-Valent Pneumococcal Conjugate Vaccine Vaxneuvance
Vaxneuvance consists of pneumococcal polysaccharides from 15 serotypes, including serotypes 22F and 33F.
FDA Approves 20-Valent Pneumococcal Conjugate Vaccine Prevnar 20
The vaccine contains capsular polysaccharide conjugates for 7 additional serotypes (8, 10A, 11A, 12F, 15B, 22F and 33F) that cause invasive pneumococcal disease.
Oral-Only Dosing Regimen of Nuzyra Approved for CABP
Previously, the initial loading dose of Nuzyra for CABP was administered only by IV infusion.
Novel Pneumococcal Conjugate Vaccine Immunogenic, Safe in Pediatric Trials
Positive topline results were announced from two phase 3 studies evaluating V114, an investigational 15-valent pneumococcal conjugate vaccine, in pediatric patients for the prevention of invasive pneumococcal disease.
ACP Offers Guidance on Antibiotic Duration for Common Infections
Best practices recommend limiting antibiotics to five days for COPD exacerbations, acute uncomplicated bronchitis
Mortality, Readmission Low With COVID-19 Discharge on Home Oxygen
All-cause mortality rate 1.3 percent; 30-day readmission rate 8.5 percent among 621 patients discharged on home oxygen
